Fluid Resuscitation in Patients Suffering From Burns Injury

NCT01689506 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

11

Enrollment

INDUSTRY

Sponsor class

Stopped Study stopped due to low recruitment

Conditions

Burns

Interventions

DRUG: Volulyte
DRUG: Human Serum Albumin

Sponsor

Fresenius Kabi